Inhibition of vasoconstriction by the thromboxane A2 antagonist GR32191B in the human radial artery

British Journal of Clinical Pharmacology

Volumn 48, Issue 2, 1999, Pages 207-215

  He, Guo Wei ^a   Yang, Cheng Qin ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

Coronary bypass; GR32191B; Human artery; Internal mammary artery; Radial artery; Thromboxane A2; Thromboxane antagonists

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN; NORADRENALIN; PROSTAGLANDIN F2 ALPHA; PROSTANOID RECEPTOR; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; VAPIPROST; VASOCONSTRICTOR AGENT;

ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG POTENCY; DRUG SPECIFICITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RADIAL ARTERY; VASOCONSTRICTION; VASOSPASM;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANGIOTENSIN II; BIPHENYL COMPOUNDS; CORONARY ARTERY BYPASS; DINOPROST; HEPTANOIC ACIDS; HUMANS; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; POTASSIUM; PROSTAGLANDIN ANTAGONISTS; RADIAL ARTERY; THROMBOXANE A2; VASOCONSTRICTOR AGENTS;

EID: 0032769402     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00985.x     Document Type: Article

References (27)

1. 1 Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314: 1-6.
2. 2 Acar C, Jebara VA, Portoghese M, et al. Revival of the radial artery for coronary bypass grafting. Ann Thorac Surg 1992; 54: 652-660.
3. 3 Carpentier A, Guermonprez JZ, Deloche A, Frechette C, Dubost C. The aorto to-coronary radial artery bypass graft: a technique avoiding pathological changes in grafts. Ann Thorac Surg 1973; 16: 111-121.
4. 4 Carpentier A, Discussion of Geha AS, Krone RJ, McCormick JR, Baue AE. Selection of coronary bypass: anatomic, physiological, and angiographic considerations of vein and mammary artery grafts. J Thorac Cardiovasc Surg 1975; 70: 414-431.
5. 5 He G-W, Yang C-Q. Radial artery has higher receptor-selective contractility but similar endothelium function compared to mammary artery. Ann Thorac Surg 1997; 63: 1346-1352.
6. 6 He G-W, Yang C-Q. Comparison among arterial grafts and coronary artery. An attempt at functional classification. J Thorac Cardiovasc Surg 1995; 109: 707-715.
7. 7 Chardigny C, Jebara VA, Acar C, et al. Vasoreactivity of the radial artery. Comparison with the internal mammary artery and gastroepipoic arteries with implications for coronary artery surgery. Circulation 1993;88[part II]: 115-127.
8. 2 levels during cardiopulmonary bypass. Circulation 1980; 61: 803-813.
9. 9 He G-W, Buxton B, Rosenfeldt F, Angus JA. Reactivity of human isolated internal mammary artery to constrictor and dilator agents. Implications for treatment of internal mammary artery spasm. Circulation 1989; 80(Suppl): I-141-I-150.
10. 10 He G-W, Yang C-Q. Use of verapamil and nitroglycerin solution for preparation of radial artery for coronary bypass grafting. Ann Thorac Surg 1996; 61: 610-614.
11. 11 Jones RL, Wilson NH, Lawrence RA. EP 171: a high affinity thromboxane A2-mimetic, the actions of which are slowly reversed by receptor blockade. Br J Pharmacol 1989; 96: 875-887.
12. 2 receptor-blocking drug, GR32191, in healthy subjects. Circulation 1990; 819(Suppl): I-53-I-58.
13. 13 Lumley P, White BP, Humphrey PPA. GR32191: a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Br J Pharmacol 1989; 97: 783-794.
14. 2 receptor blocking activity of GR 32191 in man. Br J Clin Pharmacol 1988; 26: 662P.
15. 2 antagonist GR 32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery. J Cardiovasc Pharmacol 1988; 26: 13-19.
16. 16 He G-W, Angus JA, Rosenfeldt FL. Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: Relevance to coronary bypass graft surgery. J Cardiovasc Pharmacol 1988; 12: 12-22.
17. 17 He G-W, Yang C Q, Graier WF, Yang J-A. Hyperkalemia alters EDHF-mediated hyperpolarization and relaxation in coronary arteries. Am J Physiol 1996; 271: H760-H767.
18. 18 He G W, Yang C-Q, Starr A. An overview of the nature of vasoconstriction in arterial grafts for coronary surgery. Ann Thorac Surg 1995; 59: 676-683.23.
19. 19 He G-W, Yang C Q. Inhibition of vasoconstriction by the potassium channel opener aprikalim in human conduit arteries. Br J Clin Pharmacol 1997; 44: 353-359.
20. 20 He G-W, Yang C Q. Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts. J Cardiovasc Pharmacol 1996; 28: 208-214.
21. 21 Kulatilake N, Gonzalez-Lavin L, Grover GJ. Thromboxane A2 receptor blockade improves contractile function following cardiopulmonary bypass in dogs and pigs. J Surg Res 1991; 51: 336-340.
22. 22 He G-W, Yang C-Q, Gately H, et al. Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries. Br J Clin Pharmacol 1996; 41: 101-107.
23. 23 Ritter JM, Benjamin N, Doktor HS, et al. Effects of selective thromboxane receptor antagonist (GR 32191B): and of glyceryl trinitrate on bleeding time in man. Br J Clin Pharmacol 1990; 29: 431-436.
24. 24 Kennedy I, Coleman RA, Humphrey PPA, Levy GP, Lumley P. Studies on the characterization of prostanoid receptors: a proposed classification. Prostaglandins 1982; 24: 667-689.
25. 25 Armour CL, Johnson PRA, Aifredson ML, Black JL. Characterization of contractile prostanoid receptors on human airway smooth muscle. Eur J Pharmacol 1989; 165: 215-222.
26. 26 Featherstone RL, Robinson C, Holgate ST, Church MK. Observations on thromboxane receptor-mediated contraction of guinea pig and human airways by other prostaglandins. Br J Pharmacol 1988; 94: 336P.
27. 27 Senior J, Sangha R, Baxter GS, Marshall K, Clayton JK. In vitro characterization of prostanoid FP-, DP-, IP-and TP-receptors on the non-pregnant human myometrium. Br J Pharmacol 1992; 107: 215-221.